JP2016513523A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513523A5
JP2016513523A5 JP2015562517A JP2015562517A JP2016513523A5 JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5 JP 2015562517 A JP2015562517 A JP 2015562517A JP 2015562517 A JP2015562517 A JP 2015562517A JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5
Authority
JP
Japan
Prior art keywords
solution
item
bile
seq
target area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015562517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/059765 external-priority patent/WO2014141160A1/en
Publication of JP2016513523A publication Critical patent/JP2016513523A/ja
Publication of JP2016513523A5 publication Critical patent/JP2016513523A5/ja
Pending legal-status Critical Current

Links

JP2015562517A 2013-03-14 2014-03-13 胆汁漏の処置 Pending JP2016513523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784496P 2013-03-14 2013-03-14
US61/784,496 2013-03-14
PCT/IB2014/059765 WO2014141160A1 (en) 2013-03-14 2014-03-13 Treatment for bile leakage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018079164A Division JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Publications (2)

Publication Number Publication Date
JP2016513523A JP2016513523A (ja) 2016-05-16
JP2016513523A5 true JP2016513523A5 (enExample) 2017-04-13

Family

ID=50397217

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562517A Pending JP2016513523A (ja) 2013-03-14 2014-03-13 胆汁漏の処置
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Country Status (5)

Country Link
US (1) US20160030628A1 (enExample)
EP (1) EP2968654A1 (enExample)
JP (2) JP2016513523A (enExample)
HK (1) HK1220145A1 (enExample)
WO (1) WO2014141160A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3238749B2 (en) 2008-10-06 2025-06-04 3-D Matrix, Ltd. Tissue plug
EP3466964A1 (en) 2012-07-06 2019-04-10 3-D Matrix Ltd. Fill-finish process for peptide solutions
EP3628337B1 (en) 2014-03-10 2025-05-28 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
CN117138022A (zh) 2014-03-10 2023-12-01 三维矩阵有限责任公司 自组装肽组合物
WO2015138478A1 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
CN109152868A (zh) * 2016-03-18 2019-01-04 立美基股份有限公司 防止生物组织粘连
US20200078489A1 (en) * 2016-03-18 2020-03-12 3-D Matrix, Ltd. Pancreatic fistula occlusion
EP3429645A1 (en) * 2016-03-18 2019-01-23 3-D Matrix, Ltd Cerebrospinal fluid leakage occlusion
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031466B1 (en) * 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
ES2427565T3 (es) * 2005-04-25 2013-10-31 Massachusetts Institute Of Technology Péptidos autoensambladores para promover la hemostasia
EP3238749B2 (en) * 2008-10-06 2025-06-04 3-D Matrix, Ltd. Tissue plug
US8962784B2 (en) * 2008-12-19 2015-02-24 Ethicon, Inc. Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant

Similar Documents

Publication Publication Date Title
JP2016515113A5 (enExample)
Tyler et al. Nanomedicine for treating spinal cord injury
ES2898655T3 (es) Métodos de reparación y regeneración de tejidos
JP2017513927A5 (enExample)
JP2017519568A5 (enExample)
CA2703234C (en) An inhalable dry powder formulation comprising glp-1 for use by pulmonary inhalation
JP2017513928A5 (enExample)
JP2018130552A (ja) 胆汁漏の処置
JP2016501066A5 (enExample)
JP2016539921A5 (enExample)
JP2017513927A (ja) 肺の漏出を治療するための自発組織化ペプチド
EP4309722A3 (en) Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
RU2016127558A (ru) Стероидное соединение для применения в лечении печеночной энцефалопатии
KR102200656B1 (ko) 마이크로스피어를 포함하는 개선된 창상 치료 조성물
JP2019508175A (ja) 膵液瘻の閉鎖
JP2016535044A (ja) 次亜塩素酸ナトリウムを含む抗炎症溶液
JP2019518569A5 (enExample)
RU2018100879A (ru) Быстродействующая распадающаяся в ротовой полости пленка для проведения местного обезболивания
JP2019518569A (ja) 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola
US20170258716A1 (en) Anti-cancer agent for use in combination therapy of high intensity focused ultrasound therapy and anti-cancer agent therapy
Gan et al. Treatment of postoperative pain in major abdominal surgery with SABER®-Bupivacaine: Results of the BESST trial
AU2021324656A1 (en) Topical and parenteral use and administration of self-assembling amphiphilic peptide hydrogels
WO2021022112A1 (en) Alginate-based microcapsulation for the delivery of alpha-cgrp in cardiovascular diseases